Could LSD be a new treatment for severe anxiety?
NCT ID NCT05407064
Summary
This study tested whether a drug based on LSD (called MM120) could help reduce symptoms of generalized anxiety disorder. About 200 adults with significant anxiety received one of four different doses or a placebo (inactive substance) to see which worked best. Researchers measured changes in anxiety, depression, sleep, and daily function over 12 weeks to find the most effective and safe dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY GENERALIZED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adams Clinical
Watertown, Massachusetts, 02472, United States
-
BioBehavioral Research of Austin
Austin, Texas, 78759, United States
-
CNS Healthcare - Orlando
Orlando, Florida, 32801, United States
-
Cedar Clinical Research
Draper, Utah, 84020, United States
-
Cedar Clinical Research - Murray
Murray, Utah, 84107, United States
-
GMI - Princeton Medical Institute
Princeton, New Jersey, 08540, United States
-
Great Lakes Clinical Trials
Chicago, Illinois, 60640, United States
-
Hassman Research Institute
Berlin, New Jersey, 08009, United States
-
Irvine Center for Clinical Research
Irvine, California, 92614, United States
-
Kadima Neuropsychiatry Institute
La Jolla, California, 92037, United States
-
Lutheran Hospital - Cleveland Clinic
Cleveland, Ohio, 44113, United States
-
Mountain View Clinical Research
Denver, Colorado, 80209, United States
-
Pacific Neuroscience Institute
Santa Monica, California, 90404, United States
-
Preferred Research Partners
Little Rock, Arkansas, 72211, United States
-
SISU
Springfield, Massachusetts, 01103, United States
-
Segal Trials
Lauderhill, Florida, 33319, United States
-
Sunstone Therapies
Rockville, Maryland, 20850, United States
-
University of Texas Health Houston
Houston, Texas, 77054, United States
-
Uptown Research
Chicago, Illinois, 60640, United States
-
Wholeness Center
Fort Collins, Colorado, 80525, United States
-
Woodstock Research Center
Woodstock, Vermont, 05091, United States
-
iResearch Atlanta
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.